Clinical trial · Interventional
IVF\ICSI Outcome in Women With Polycystic Ovary Syndrome
IVF\ICSI Outcome in Women With Polycystic Ovary Syndrome Compared With Non Polycystic Ovary Syndrome Women
NCT05756023CI-TRIAL-00070606recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Polycystic ovarian syndrome (PCOS) occurs in 5% to 10% of all women of reproductive age and 50% of women who present with sub-fertility due to anovulatory infertility . Clear diagnostic criteria for this condition were identified at the consensus meeting of the European Society of Human Reproduction and Embryology and the American Society for Reproductive Medicine .
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| the pregnancy rate at IVF / ICSI cycles | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- PCOs Patients
- description
- To compare the pregnancy rate at IVF / ICSI cycles in patients with PCOs
- interventionNames
- Procedure: the pregnancy rate at IVF / ICSI cycles
- type
- ACTIVE_COMPARATOR
- label
- Non PCOs Patients
- description
- To compare the pregnancy rate at IVF / ICSI cycles in patients with without PCOs
- interventionNames
- Procedure: the pregnancy rate at IVF / ICSI cycles
Primary outcomes (1)
- measure
- pregnancy rate
- timeFrame
- From baseline to 15 days after the embryo transfere day.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 35 Years
Show eligibility criteria text
Inclusion Criteria: * Oligo-ovulation or anovulation. * Clinical and/or biochemical hyper androgenesim. * Polycystic ovaries. Exclusion Criteria: 1. Androgen-secreting tumors (ovarian or adrenal). 2. Adult-onset congenital adrenal hyperplasia. 3. Thyroid diseases. 4. Cushing's syndrome. 5. Diabetes Mellitus. 6. recurrent ICSI failure 7. endocrine, hematologic and autoimmune disorders 8. Non chromosomal and genetic abnormalities 9. Major uterine anomalies, bad surgical history, sever endometriosis, , hydrosalpinx, uterine fibroids 10. Azospermia
References
Publications (0)
Data not yet available
No reference posted for this study.